Noema Pharma
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $170M
Investors
- 9
About Noema Pharma
Noema Pharma AG, established in 2019, specializes in the development of therapies for central nervous system conditions. The company was founded by George Garibaldi and Luigi Costa, with Ilise Lombardo serving as CEO.Noema Pharma specializes in developing innovative therapies aimed at addressing various central nervous system (CNS)-mediated conditions. The company's primary products include three mid-clinical-stage therapeutics that target persistent seizures related to Tuberous Sclerosis Complex, severe pain from Trigeminal Neuralgia, and involuntary tics associated with Tourette Syndrome. Additionally, they focus on Childhood Onset Fluency Disorder and menopausal symptoms like vasomotor symptoms (VMS).Noema Pharma's revenue model is built around partnerships and collaborations aimed at commercializing its therapeutics. The company engages directly with healthcare organizations to deliver its mid-clinical-stage products to patients post-clinical trials and approvals. Noema Pharma plans to launch new products designed to address significant medical needs and expand into diverse geographic regions, although specific markets and release dates have not been disclosed.
Who invested in Noema Pharma
9 investors across 4 rounds
See all investors in Noema Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Noema Pharma
Who invested in Noema Pharma?
Noema Pharma has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Noema Pharma raised?
Noema Pharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Noema Pharma last raise money?
Noema Pharma's most recent round on record is a Series B, in Dec 2024.
What does Noema Pharma do?
Noema Pharma AG, established in 2019, specializes in the development of therapies for central nervous system conditions.
Where is Noema Pharma headquartered?
Noema Pharma is headquartered in Basel, Switzerland.
Which VCs invest in companies like Noema Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Noema Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Noema Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.